Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$67.50
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | BMY Avg Daily Volume: 6,202,300
Last Update: 05/26/15 - 4:01 PM EDT
Volume: 0
YTD Performance: 14.35%
Open: $0.00
Previous Close: $67.50
52 Week Range: $46.30 - $69.86
Oustanding Shares: 1,666,974,545
Market Cap: 113,854,361,424
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 9 9
Moderate Buy 1 1 0 0
Hold 4 5 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.89 1.97 2.06 2.06
Latest Dividend: 0.37
Latest Dividend Yield: 2.17%
Dividend Ex-Date: 04/01/15
Price Earnings Ratio: 50.59
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
50.59 50.80 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.83% 38.35% 103.99%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 -0.25 -0.09
Net Income -21.40 -0.61 -0.27
EPS -22.20 -0.44 -0.18
Earnings for BMY:
EBITDA 3.06B
Revenue 15.88B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.34 $0.37 $1.72 $2.29
Number of Analysts 10 9 12 12
High Estimate $0.41 $0.42 $1.86 $2.54
Low Estimate $0.30 $0.28 $1.64 $2.05
Prior Year $0.48 $0.45 $1.85 $1.72
Growth Rate (Year over Year) -28.33% -18.52% -6.94% 33.06%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
You could throw darts at financials and health care and win. 
The stock is extending Friday's breakout move.
Update
May 05, 2015 | 6:37 AM EDT
BMY - Bristol-Myers Squibb Co Annual Shareholders Meeting - 10AM
Apple is higher after-hours on better-than-expected results.
Futures point slightly higher as the juggernaut report draws near.
Big day for Microsoft -- Xerox, not so much.

Rigs Reduction Real Money Pro($)

The market is about at the same levels as it was during my last update an hour and a half go. Baker Hughes' (BHI) latest survey shows domestic rigs falling for the 20th consecutive week, bringing the total number of active rigs down to 703 from their October peak of about 1,600. Now that is a major adjustment in a relatively short period of time. How many jobs got whacked as a result is a question I would like to know the answer to.
Biogen miss no reason to abandon big 4 of Big Pharma.
Bullish
Apr 21, 2015 | 6:51 AM EDT
BMY was upgraded from Equal-weight to Overweight, Morgan Stanley said. $80 price target. Estimates also upped, given early success of O...
Combined Heinz-Kraft heads a long second-quarter list.

Columnist Conversations

The IRS said that identity thieves had accessed about 100,000 U.S. households' tax records through "Get Transc...
Seems to be continuing rather strongly since April. Just sayin'...
The transports are breaking below the base support line of a large triangle top pattern on the weekly chart, a...
is this the beginning of the end for Jony Ive at AAPL? http://t.co/Ohw2qEL0w9

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.